Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	279,443	262,358	303,932	208,882	537,705	405,432
Market Cap Growth	4.06%	-13.68%	45.50%	-61.15%	32.63%	-
Enterprise Value	250,447	236,321	286,055	175,977	508,469	390,204
Last Close Price	1696.10	1577.70	1809.55	1243.71	3209.33	2430.35
PE Ratio	32.99	37.56	39.35	26.74	44.38	40.67
Forward PE	26.18	27.55	29.26	17.57	35.96	34.98
PS Ratio	4.57	4.67	5.37	5.76	12.22	11.71
PB Ratio	2.92	2.87	3.48	2.63	7.51	6.87
P/TBV Ratio	3.05	2.98	3.63	2.63	7.53	6.87
P/FCF Ratio	-	49.48	50.08	146.03	192.42	107.78
P/OCF Ratio	-	28.68	30.49	57.39	68.00	67.02
PEG Ratio	0.90	1.60	1.58	1.59	1.44	1.53
EV/Sales Ratio	4.10	4.21	5.05	4.86	11.55	11.27
EV/EBITDA Ratio	17.42	19.19	22.06	17.07	33.67	29.97
EV/EBIT Ratio	24.21	27.10	29.45	19.90	36.32	32.42
EV/FCF Ratio	-	44.57	47.14	123.03	181.96	103.74
Debt / Equity Ratio	0.03	0.03	0.04	0.00	0.00	0.00
Debt / EBITDA Ratio	0.21	0.25	0.28	0.00	0.00	0.00
Debt / FCF Ratio	-	0.59	0.61	0.03	0.02	0.01
Net Debt / Equity Ratio	-0.30	-0.29	-0.18	-0.47	-0.45	-0.51
Net Debt / EBITDA Ratio	-2.04	-2.14	-1.21	-3.64	-2.15	-2.30
Net Debt / FCF Ratio	-	-4.98	-2.58	-26.27	-11.60	-7.97
Asset Turnover	-	0.51	0.58	0.44	0.61	0.65
Inventory Turnover	-	1.44	1.40	1.16	1.79	1.56
Quick Ratio	-	3.01	2.61	6.58	7.80	7.31
Current Ratio	-	4.34	4.04	9.46	10.06	10.00
Return on Equity (ROE)	-	7.82%	9.26%	10.33%	18.55%	20.88%
Return on Assets (ROA)	-	4.98%	6.25%	6.65%	12.21%	14.22%
Return on Invested Capital (ROIC)	10.55%	8.39%	11.67%	16.14%	30.73%	34.27%
Return on Capital Employed (ROCE)	-	9.00%	10.50%	11.00%	19.30%	20.10%
Earnings Yield	3.03%	2.66%	2.54%	3.74%	2.25%	2.46%
FCF Yield	-	2.02%	2.00%	0.69%	0.52%	0.93%
Dividend Yield	1.04%	1.14%	1.10%	-	-	-
Payout Ratio	-	47.17%	-	-	-	-
Buyback Yield / Dilution	-0.02%	-0.01%	-0.03%	-0.09%	-3.96%	-2.15%
Total Shareholder Return	1.03%	1.13%	1.07%	-0.09%	-3.96%	-2.15%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.